Early Menopause Increases Risk of Lung Diseases in Smokers, Study Finds

Early Menopause Increases Risk of Lung Diseases in Smokers, Study Finds

Early menopause has been linked to a higher risk of lung diseases and poor health outcomes among smokers, according to a recent study published on June 13 in Thorax.

A study led by Dr. Xiaochun Gai from the University of New Mexico School of Medicine examined whether early menopause caused by surgery impacts lung health and if menopausal hormone therapy (MHT) offers protection against lung diseases. Data from 69,706 postmenopausal women were analyzed.

Exercise may reduce breast cancer risk

Exercise, even mild physical activity, may reduce breast cancer risk – A new analysis done by University of North Carolina at Chapel Hill researchers has found that physical activity ? either mild or intense and before or after menopause ? may reduce breast cancer risk, but substantial weight gain may negate these benefits. The findings indicate that women can reduce their breast cancer risk by exercising and maintaining their weight.

Increasing height and body mass index linked to ovarian cancer risk

Increasing height and body mass index are risk factors for ovarian cancer – Increasing height and, among women who have never taken menopausal hormone therapy, increased body mass index are risk factors for developing ovarian cancer in women, revealed by researchers.

Heartburn and acid reflex medicines increase hip fracture risk

Women taking indigestion drugs at increased risk of hip fracture after menopause – A prospective study of proton pump inhibitor use and risk of hip fracture in relation to dietary and lifestyle factors – Post-menopausal women are 35% more likely to suffer hip fracture if they take indigestion drugs, known as proton pump inhibitors (PPIs), a figure which increases to 50% if they are also current or former smokers.

Pfizer new drug could provide a new treatment option for postmenopausal women

Pfizer new drug BZA/CE could provide a new treatment option for symptomatic postmenopausal women with a uterus – Pfizer Inc. will announce new one-year results from the Selective estrogens, Menopause, And Response to Therapy [SMART]-5 Phase 3 study of the safety and efficacy of the investigational tissue selective estrogen complex (TSEC) bazedoxifene/conjugated estrogens (BZA/CE) at the 22nd annual meeting of the North American Menopause Society (NAMS), September_21-24 in Washington, D.C.

Soy isoflavone tablets not reducing bone loss or menopausal symptoms

Soy tablets not associated with reduction in bone loss or menopausal symptoms in women – Soy isoflavone tablets do not appear to reduce bone loss or menopausal symptoms in women within the first five years of menopause, revealed by researchers recently in a study reported in Archives of Internal Medicine.

Therapy reduces early menopause for women with breast cancer

Therapy appears to reduce rate of chemotherapy-induced early menopause for women with breast cancer – Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.